1. Home
  2. EVR vs BMRN Comparison

EVR vs BMRN Comparison

Compare EVR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$332.15

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.19

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVR
BMRN
Founded
1995
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
10.5B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
EVR
BMRN
Price
$332.15
$53.19
Analyst Decision
Buy
Buy
Analyst Count
9
19
Target Price
$320.11
$88.42
AVG Volume (30 Days)
344.0K
3.0M
Earning Date
10-29-2025
10-27-2025
Dividend Yield
1.01%
N/A
EPS Growth
61.11
59.53
EPS
12.55
2.68
Revenue
$3,542,875,000.00
$3,094,001,000.00
Revenue This Year
$25.39
$13.39
Revenue Next Year
$16.43
$7.57
P/E Ratio
$26.43
$19.92
Revenue Growth
27.03
12.39
52 Week Low
$148.63
$50.76
52 Week High
$364.42
$73.51

Technical Indicators

Market Signals
Indicator
EVR
BMRN
Relative Strength Index (RSI) 62.83 46.19
Support Level $310.93 $53.03
Resistance Level $322.82 $54.66
Average True Range (ATR) 11.11 1.45
MACD 3.21 -0.11
Stochastic Oscillator 87.16 31.61

Price Performance

Historical Comparison
EVR
BMRN

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: